“…Following this event, identification of EV-D68 in wastewater samples showed very close resemblance to clinical data reported in the UK, where peaks of EV-D68 detection in human respiratory samples were observed in January 2016, July 2016 and September 2018, and very few cases were reported between November 2016 and July 2018, as shown in the two separate studies from Wales and England discussed above (Cottrell et al 2018, Public Health England 2019). Reports of EV-D68 detection were also abundant in other European countries during the same periods in 2016 and 2018 (Bal et al 2019, Cassidy et al 2018). An upsurge of EV-D68 detection in wastewater samples from both locations was observed between August and December 2018 in agreement with recent reports of increased EV-D68 detection likely associated with AFM cases in the UK, following similar reports in the USA (Centers for Disease Control and Prevention (CDC) 2019, The United Kingdom Acute Flaccid Paralysis Afp Task 2019).…”